Igen Biolab Group
  • Home
  • About us
  • Pipeline
  • Tecnology
  • Press
    • News
    • Press Releases
    • Events
    • Publications
  • Contact
  • English
    • Español
Select Page
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

by Igen BioLab Group | Mar 3, 2022 | News, Publications

Previous studies have suggested that the gut microbiome influences the response to checkpoint inhibitors (CPIs) in patients with cancer. CBM588 is a bifidogenic live bacterial product that we postulated could augment CPI response through modulation of the gut...
Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy

Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy

by Igen BioLab Group | Feb 10, 2022 | News, Publications

Research on the relationship between microbiome and cancer has made significant progress in the past few decades. It is now known that the gut microbiome has multiple effects on tumour biology. However, the relationship between intratumoral bacteria and cancers...
Adding single type of bacteria to gut microbiome boosted anti-tumor immunity in mice Peer-Reviewed Publication

Adding single type of bacteria to gut microbiome boosted anti-tumor immunity in mice Peer-Reviewed Publication

by Igen BioLab Group | Dec 9, 2021 | Publications

A bacterium common in the mouse gut microbiome can charge up the immune system to fight cancer cells in the colon, researchers from the University of Pittsburgh School of Medicine report today in the journal Immunity.    The study showed that bacterium Helicobacter...
Hormone-producing bacteria drive prostate cancer

Hormone-producing bacteria drive prostate cancer

by Igen BioLab Group | Nov 12, 2021 | Publications

During androgen-deprivation therapy, certain bacteria in the gut can synthesize androgens, thereby promoting tumor progression and therapy resistance. Androgen-deprivation therapy (ADT) removes the hormones that fuel prostate tumor growth and is the standard treatment...
Gut Bacteria may Fuel prostate Cancer Treatment Resistance

Gut Bacteria may Fuel prostate Cancer Treatment Resistance

by Igen BioLab Group | Oct 25, 2021 | Publications

A mainstay of treatment for prostate cancer is to deprive it of androgens, the hormones that make it grow. The testes are the main source of these hormones, so treatment can consist of either surgical removal of these organs or use of drugs to block...
« Older Entries

Recent Posts

  • Special Issue “Microbiome in Cancer: Role in Carcinogenesis and Impact in Therapeutic Strategies”
  • Microbiota contributions
  • Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer
  • The microbiome and human cancer
  • The intestinal microbiota in colorectal cancer metastasis – Passive observer or key player?
  • LEGAL NOTICE
  • PRIVACY AND DATA PROTECTION
  • Cookie policy
  • Facebook
  • Twitter
  • Instagram
  • RSS
Design by loComunicas

This website uses its own and third-party cookies in order to analyze the traffic generated for statistical purposes.

You can accept all cookies by clicking "Accept", reject all of them by clicking "Deny" or configure them by clicking "Settings".

For more information on how this site uses cookies and related technologies, you can read our Policy on Cookies

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly necessary cookies

Strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

If you deactivate this cookie, we will not be able to save your preferences. This means that every time you visit this website you will have to activate or deactivate cookies again.

Third party cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Please activate the strictly necessary cookies first so that we can save your preferences!

Cookies policy

More information about our cookie policy